[{"address1": "PMB #117, 2801 Centerville Road", "address2": "1st Floor", "city": "Wilmington", "state": "DE", "zip": "19808-1609", "country": "United States", "phone": "877 354 3689", "website": "https://eliemtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Andrew  Levin M.D., Ph.D.", "age": 45, "title": "Principal Financial Officer & Executive Chairman", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 65387, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Valerie  Morisset Ph.D.", "age": 53, "title": "Chief Scientific Officer and Executive VP of Research & Development", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 1077620, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jo  Palmer-Phillips Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.39, "open": 8.4, "dayLow": 8.4, "dayHigh": 11.53, "regularMarketPreviousClose": 8.39, "regularMarketOpen": 8.4, "regularMarketDayLow": 8.4, "regularMarketDayHigh": 11.53, "beta": 0.509, "forwardPE": -19.528847, "volume": 1477735, "regularMarketVolume": 1477735, "averageVolume": 824822, "averageVolume10days": 862940, "averageDailyVolume10Day": 862940, "bid": 10.08, "ask": 10.22, "bidSize": 200, "askSize": 200, "marketCap": 281535168, "fiftyTwoWeekLow": 2.34, "fiftyTwoWeekHigh": 11.53, "fiftyDayAverage": 3.4075, "twoHundredDayAverage": 2.851435, "currency": "USD", "enterpriseValue": 175041600, "floatShares": 4773282, "sharesOutstanding": 27723800, "sharesShort": 601081, "sharesShortPriorMonth": 13000, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0217, "heldPercentInsiders": 0.2612, "heldPercentInstitutions": 0.67291, "shortRatio": 0.3, "shortPercentOfFloat": 0.067600004, "impliedSharesOutstanding": 27723800, "bookValue": 3.885, "priceToBook": 2.6138995, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -35119000, "trailingEps": -1.3, "forwardEps": -0.52, "52WeekChange": 1.4896142, "SandP52WeekChange": 0.22379243, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "ELYM", "underlyingSymbol": "ELYM", "shortName": "Eliem Therapeutics, Inc", "longName": "Eliem Therapeutics, Inc.", "firstTradeDateEpochUtc": 1628602200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "1b4f0889-5a57-3355-b4cd-22b070a75c16", "messageBoardId": "finmb_603195850", "gmtOffSetMilliseconds": -14400000, "currentPrice": 10.155, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 106798000, "totalCashPerShare": 3.853, "totalDebt": 349000, "quickRatio": 38.553, "currentRatio": 38.918, "debtToEquity": 0.324, "returnOnAssets": -0.10931, "returnOnEquity": -0.29722, "freeCashflow": 3461750, "operatingCashflow": -20599000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-04"}]